Search - tctmd.com

Displaying 161 - 180 of 252

Sort: Relevancy | Date

Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF

News Conference News AHA 2020

Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF

November 16, 2020

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

News Conference News AHA 2020

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

November 13, 2020

Clinical Trial Conduct in the COVID-19 Era: A Road Map

News Daily News

Clinical Trial Conduct in the COVID-19 Era: A Road Map

November 12, 2020

News Features

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

November 02, 2020

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

News Daily News

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

September 23, 2020

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

News Conference News ESC 2020

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

August 30, 2020

‘Striking Similarities’ for COVID-19 Inflammatory Syndromes in Children, Adults

News Daily News

‘Striking Similarities’ for COVID-19 Inflammatory Syndromes in Children, Adults

August 17, 2020

TCTMD’s Top 10 Most Popular Stories for July 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

July 31, 2020

CMS Releases Proposed Updates for Coverage of Transcatheter MV Repair

News Daily News

CMS Releases Proposed Updates for Coverage of Transcatheter MV Repair

July 01, 2020

Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms

News Daily News

Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms

May 21, 2020

Subcutaneous ICD Holds Up Well Against Transvenous Devices

News Conference News HRS 2020

Subcutaneous ICD Holds Up Well Against Transvenous Devices

May 13, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

March 17, 2020

Trials of New Cancer Drugs Failing to Address Potential CV Risks

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

February 10, 2020

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

News Daily News

Diastolic Dysfunction Does Not Negate Health Status Benefits of TAVR

November 27, 2019

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

News Daily News

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

November 20, 2019

Dapagliflozin Has Benefits Across Heart Failure Subgroups

News Conference News AHA 2019

Dapagliflozin Has Benefits Across Heart Failure Subgroups

November 17, 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

November 11, 2019

TCTMD’s Top 10 Most Popular Stories for October 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

October 31, 2019

Primary Prevention ICDs Still Render Better Survival, Even in Modern HFrEF Patients

News Conference News ESC 2019

Primary Prevention ICDs Still Render Better Survival, Even in Modern HFrEF Patients

September 13, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.